Trials / Unknown
UnknownNCT05088733
Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia (YYFZJDTIHBVRHCIA)
Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Beijing Ditan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Clinical research of Yang Yin Fu Zheng Jie Du therapy in HBV related hepatocellular carcinoma induced anemia. The purpose of this study is to observe the efficacy of routine medical care combined with Yang Yin Fu Zheng Jie Du therapy for patients belong to HBV-HCC induced anemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Yang Yin Fu Zheng Jie Du therapy | Yang Yin Fu Zheng Jie Du is a Chinese herbal compound. |
| OTHER | Routine medical care | Routine medical care |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
- First posted
- 2021-10-22
- Last updated
- 2021-11-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05088733. Inclusion in this directory is not an endorsement.